HEALWELL AI Inc. Stock: price and insider trades · Canada
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate HEALWELL AI Inc. Strong Buy (bullish), based on 11 analysts. Average price target: CA$1.84.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 16,385 sharesClass A Subordinate Voting SharesTSXSEDI:4748751
- 16,385 sharesPerformance Share UnitsTSXSEDI:4748750
- 28,846 sharesPerformance Share UnitsTSXSEDI:4748504
- 28,846 sharesRestricted Share UnitsTSXSEDI:4748502
- 153,846 sharesRestricted Share UnitsTSXSEDI:4748500
- 76,923 sharesPerformance Share UnitsTSXSEDI:4748299
- 76,923 sharesRestricted Share UnitsTSXSEDI:4748298
- 153,846 sharesRestricted Share UnitsTSXSEDI:4748296
- 192,307 sharesRestricted Share UnitsTSXSEDI:4748212
- 192,307 sharesPerformance Share UnitsTSXSEDI:4748210
- 128,205 sharesPerformance Share UnitsTSXSEDI:4748209
- 87,918 sharesPerformance Share UnitsTSXSEDI:4748181
- 87,918 sharesRestricted Share UnitsTSXSEDI:4748180
- 175,837 sharesRestricted Share UnitsTSXSEDI:4748179
- 112,179 sharesPerformance Share UnitsTSXSEDI:4748172
- 112,179 sharesRestricted Share UnitsTSXSEDI:4748169
- 224,358 sharesRestricted Share UnitsTSXSEDI:4748167
- 128,205 sharesPerformance Share UnitsTSXSEDI:4748159
- 128,205 sharesRestricted Share UnitsTSXSEDI:4748157
- 256,410 sharesRestricted Share UnitsTSXSEDI:4748155
- 105,633 sharesClass A Subordinate Voting SharesTSXSEDI:4741377
- 105,633 sharesPerformance Share UnitsTSXSEDI:4741376
- 35,211 sharesClass A Subordinate Voting SharesTSXSEDI:4741374
- 35,211 sharesRestricted Share UnitsTSXSEDI:4741373
- 50,000 sharesClass A Subordinate Voting SharesTSXSEDI:4741370
25 of 132 declarations
About HEALWELL AI Inc.
The heaviest purchase at HEALWELL AI Inc. is WELL Health Technologies Corp.'s: EUR 341,800 on December 22, 2023, most of the EUR 345,143 that the 5 purchases on file add up to. Alexander Julian Dobranowski, a director and senior officer, bought EUR 1,154 on November 27, 2025 and EUR 918 on November 21, 2025.
Sales are far more numerous: 27, worth EUR 303,322 (median EUR 8,084), or 16% purchases among open-market trades. Blake Corbet, a senior officer of the issuer, sold EUR 56,009 on September 24, 2025 and EUR 27,371 the next day, and Alexander Julian Dobranowski EUR 39,019 on September 19, 2025. Alexander Julian Dobranowski filed 35 of the 112 filings, including 24 sales and 4 purchases. Blake Corbet has 8, as do Anthony Lam and Sacha Gera, senior officers, and Hamed Shahbazi, a director.
Read moreShow less
The health care and pharma company, listed in Toronto, is worth CAD 220,669,312, and insiders hold 49.5% of it. Filings, published from December 11, 2023 to July 8, 2026 by 15 filers, include 19 grants, 13 option exercises and 48 filings of another kind. The year 2025 gathers 50. The last twelve months hold 37, including 4 purchases and no sale. The median publication delay is 5 days.
